BARCLAYS PLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$892
-26.0%
53,651
-16.7%
0.00%0.0%
Q2 2023$1,205
+31.4%
64,436
+28.8%
0.00%
Q1 2023$917
-41.9%
50,034
-37.2%
0.00%
-100.0%
Q4 2022$1,577
-99.9%
79,652
+76.9%
0.00%0.0%
Q3 2022$1,084,000
+2158.3%
45,026
+1610.7%
0.00%
Q2 2022$48,000
-91.7%
2,632
-90.0%
0.00%
Q1 2022$580,00026,3700.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$58,747,00054.16%
KPCB XV Associates, LLC 1,297,063$47,641,00037.58%
Ponoi II Management, LLC 145,401$5,341,0009.70%
Euclidean Capital LLC 432,900$15,900,0009.04%
Column Group LLC 1,402,008$51,496,0007.00%
AJU IB Investment Co., Ltd. 99,503$3,655,0005.09%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,148,321$42,178,0004.85%
Ghost Tree Capital, LLC 350,000$12,856,0004.61%
Velan Capital Investment Management LP 110,000$4,040,0003.14%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$16,294,0002.28%
View complete list of RAPT THERAPEUTICS INC shareholders